Studies of infused megakaryocytes into mice support a ''catch-and release'' model of pulmonary-centric thrombopoiesis
Hyun‐Jun KimiD, Danuta Jadwiga Jarocha, Ian Johnson, Hyun-Sook Ahn, Nicholas Hlinka, Deborah L. FrenchiD, Lubica RauovaiD, Kiwon LeeiD, Mortimer PoncziD
Abstract
Many aspects of thrombopoiesis, the release of platelets from megakaryocytes (Mks), remain under debate, including where this process occurs. Murine lung in situ-microscopy studies suggested that a significant fraction of circulating platelets was released from lung-entrapped, marrow-derived Mks. We now confirm these that endogenous murine (m) Mks are immobilized in the lungs. Intravenously infused in vitro-differentiated, mMks and human (h) Mks are similarly entrapped, followed by shedding of their cytoplasm over [~]30 minutes with a peak number of released platelets occurring 1.5-4 hours later. However, while infused Mks from both species shed large intrapulmonary cytoplasmic fragments that underwent further processing into platelet-sized fragments, the two differed: many mMks escaped from and then recycled back to the lungs, while most hMks were enucleated upon first intrapulmonary passage. Infused immature hMks, inflammatory hMks, umbilical cord-blood-derived hMks and immortalized Mk progenitor cell (imMKCL)-derived hMks were also immobilized in the lung of recipient mice, and released their cytoplasm, but did so to different degrees. Pharmacologically-treated hMks support that membrane stiffness was key to pulmonary thrombopoiesis. Intraarterial infused hMks resulted in few Mks being immobilized in tissues other than the lungs and was accompanied by a blunted and delayed rise in circulating human platelets. These studies demonstrate that the lung entraps and processes both circulating Mks and released large cytoplasmic fragments consistent with a prior lung/heart murine study and support a pulmonary-centric "catch-and-release" model of thrombopoiesis. Thrombopoiesis is a drawn-out process with the majority of cytoplasmic processing of Mks occurring in the pulmonary bed. Key PointsO_LIInfused in vitro-differentiated megakaryocytes synchronously release cytoplasmic fragments selectively in the pulmonary bed. C_LIO_LILarge, released megakaryocyte fragments recycle to the lungs, undergo further fission, terminally forming platelets. C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lung megakaryocytes are long-lived, arise from Flt3-negative bone marrow cells, and contribute to platelet recovery in thrombocytopenia
Alison C. Livada, Kathleen E. McGrath, … Craig N. Morrell·Journal of Clinical InvestigationPeer-reviewed·Sep 19, 2024
- Platelet generation from circulating megakaryocytes is triggered in the lung vasculature
X. Zhao, D. Alibhai, … A. W. Poole·bioRxiv·Nov 1, 2021
- Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation
Ashley P Ng, Maria Kauppi, … Warren S Alexander·bioRxiv·Mar 19, 2014
- Plasmacytoid dendritic cells regulate megakaryocyte and platelet homeostasis
F. Gaertner, H. Ishikawa-Ankerhold, … S. Massberg·bioRxiv·May 31, 2022
- Mathematical modelling of megakaryopoiesis in Mpl-deficient and continuously thrombopoietin-stimulated mice points to an unknown control mechanism
Hans H. Diebner, Andrea Gottschalk, … Ingmar Glauche·bioRxiv·May 29, 2020
- High-throughput enrichment and isolation of megakaryocyte progenitor cells from the mouse bone marrow
L. M. Bush, C. P. Healy, … T. L. Deans·bioRxiv·Nov 6, 2020